Skip to main content
. 2020 Dec 5;21(23):9292. doi: 10.3390/ijms21239292

Table 4.

The half maximal inhibitory concentration (IC50) of free paclitaxel (PTX), free paclitaxel prodrug (Pro), prodrug nanoparticles (Pro NPs), and prodrug-lapatinib nanoparticles Pro-LAP NPs compared to paclitaxel-loaded nanoparticles (PTX NPs) in ovarian cancer cell line OVCA-432.

Drug Treatment IC50 (μM)
Free PTX 83 ± 6
Free Prodrug 10 ± 5
PTX NPs 0.047 ± 0.004
Pro NPs 0.009 ± 0.002
Pro-LAP NPs: Prodrug 0.00442 ± 0.00001
LAP 0.00740 ± 0.00002